CAS 2097938-69-5: 4-[7-(4-Chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Description:The chemical substance with the name "4-[7-(4-Chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide" and CAS number "2097938-69-5" is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as sulfonamide, nitro, and various heterocycles. This compound likely exhibits significant biological activity, potentially serving as a pharmaceutical agent or a research chemical. Its structural features suggest it may interact with specific biological targets, possibly influencing pathways related to cell signaling or enzyme activity. The presence of multiple aromatic rings and heteroatoms indicates potential for diverse interactions in biological systems. Additionally, the chlorophenyl and pyrrolo groups may enhance lipophilicity, affecting its pharmacokinetic properties. Overall, this compound represents a sophisticated design in medicinal chemistry, aimed at optimizing efficacy and selectivity for therapeutic applications.
Formula:C45H48ClN7O8S
InChI:InChI=1S/C45H48ClN7O8S/c1-45(2)22-36(29-3-5-31(46)6-4-29)37-26-52-16-15-51(27-42(52)61-41(37)23-45)32-7-9-35(40(20-32)60-33-19-30-11-14-47-43(30)49-25-33)44(54)50-62(57,58)34-8-10-38(39(21-34)53(55)56)48-24-28-12-17-59-18-13-28/h3-11,14,19-21,25,28,41-42,48H,12-13,15-18,22-24,26-27H2,1-2H3,(H,47,49)(H,50,54)
InChI key:InChIKey=YOPHZZVJJKWTNO-UHFFFAOYSA-N
SMILES:O=C(NS(=O)(=O)C1=CC=C(NCC2CCOCC2)C(=C1)N(=O)=O)C3=CC=C(C=C3OC=4C=NC=5NC=CC5C4)N6CCN7CC8=C(C=9C=CC(Cl)=CC9)CC(C)(C)CC8OC7C6
- Synonyms:
- Benzamide, 4-[7-(4-chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
- 4-[7-(4-Chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Venetoclax Impurity 1 ( 3,3'-Oxy-Venetoclax, Metabolite M27) REF: 4Z-V-064003CAS: 2097938-69-5 | - - - | To inquire | Mon 31 Mar 25 |
![]() | Venetoclax-M27 REF: TR-V121010CAS: 2097938-69-5 | - - - | 39,917.00 € | Tue 06 May 25 |
![]() | Venetoclax-M27 REF: 3D-XID93869CAS: 2097938-69-5 | Min. 95% | 1,102.00 €~14,947.00 € | Mon 05 May 25 |

Venetoclax Impurity 1 ( 3,3'-Oxy-Venetoclax, Metabolite M27)
Ref: 4Z-V-064003
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

Venetoclax-M27
Controlled ProductRef: TR-V121010
25mg | 39,917.00 € |

Venetoclax-M27
Ref: 3D-XID93869
1mg | 1,102.00 € | ||
5mg | 3,114.00 € | ||
10mg | 4,983.00 € | ||
25mg | 9,342.00 € | ||
50mg | 14,947.00 € |